More than 700,000 seniors are expected to die this year from Alzheimer’s disease. It is the 6th leading cause of death in the U.S. The need for treatments is dire and Cantabio is aiming to develop a novel therapy to treat the disease. The company recently announced a new preclinical therapeutic program for Alzheimer’s Disease … Continue reading “Cantabio Pharmaceuticals Inc. (CTBO) Targets Alzheimer’s”
